Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002751093 | SCV003023884 | benign | Mucopolysaccharidosis, MPS-III-C; Retinitis pigmentosa 73 | 2024-12-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002751092 | SCV003581615 | uncertain significance | Inborn genetic diseases | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.6C>A (p.S2R) alteration is located in exon 1 (coding exon 1) of the HGSNAT gene. This alteration results from a C to A substitution at nucleotide position 6, causing the serine (S) at amino acid position 2 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |